---
schema_version: "secwatch.filing_event.v1"
accession: "0001356576-25-000006"
form_type: "8-K"
ticker: "SUPN"
cik: "0001356576"
company_name: "SUPERNUS PHARMACEUTICALS, INC."
filed_at: "2025-02-11T23:59:59+00:00"
generated_at: "2026-05-26T23:17:45.100516+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Supernus schedules Q4 and full year 2024 earnings release and call for Feb 25, 2025

## Summary
- Earnings release expected after market close on Tuesday, February 25, 2025.
- Conference call at 4:30 pm ET hosted by CEO Jack Khattar and CFO Tim Dec.
- Live webcast accessible on Supernus Investor Relations website; replay for 60 days.

## SEC filing metadata
- accession: 0001356576-25-000006
- form_type: 8-K
- ticker: SUPN
- cik: 0001356576
- company_name: SUPERNUS PHARMACEUTICALS, INC.
- filed_at: 2025-02-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/0001356576-25-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1356576/000135657625000006/supn-20250211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001356576-25-000006
- JSON: https://secwatch.observer/filing/0001356576-25-000006.json
- Plain text: https://secwatch.observer/filing/0001356576-25-000006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.